SCHEDULE 13G/A

TRAVERE THERAPEUTICS INC

Common Stock, par value $0.0001 per share · CUSIP: 89422G107

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Rock Springs Capital Management LP

  Shares: 4,973,649.00 · Class: 5.72%

• Rock Springs Capital LLC

  Shares: 4,973,649.00 · Class: 5.72%

• Rock Springs Capital Master Fund LP

  Shares: 4,180,000.00 · Class: 4.81%

• Mark Bussard

  Shares: 4,973,649.00 · Class: 5.72%

• Kris Jenner

  Shares: 4,973,649.00 · Class: 5.72%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.